Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine

Background: Although increasing clinical trials studying Shenfu injection (SFI) comprising panaxoside 0.8 mg/ml extracted from Panax ginseng C.A. Mey. and aconitine 0.1 mg/ml extracted from Aconitum carmichaeli Debeaux for elderly patients with severe pneumonia on biomarkers associated with COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shihua, Wang, Fei, Chen, Bonan, Pan, Jie, Luo, Dan, Pei, Caixia, Huang, Demei, Wang, Xiaomin, Wang, Yilan, Shen, Zherui, Li, Weihao, Wu, Yongcan, He, Yacong, Wang, Zhenxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454296/
https://www.ncbi.nlm.nih.gov/pubmed/36091817
http://dx.doi.org/10.3389/fphar.2022.779942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454296/
https://www.ncbi.nlm.nih.gov/pubmed/36091817
http://dx.doi.org/10.3389/fphar.2022.779942

Ejemplares similares